Search

Author/Creator Bae, Yun Ju

1. 546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial. (4th December 2021)

Authors:
Ison, Michael G; Kim, Jin Yong; Sandulescu, Oana; Preotescu, Liliana-Lucia; Martinez, Norma Erendira Rivera; Dobryanska, Marta; Birlutiu, Victoria; Miftode, Egidia Gabriela; Gaibu, Natalia; Caliman-Sturdza, Olga Adriana; Florescu, Simin-Aysel; Streinu-Cercel, Anca; Lee, Sang Joon; Kim, Sung Hyun;...
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S375
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019. (8th August 2022)

Authors:
Kim, Jin Yong; Săndulescu, Oana; Preotescu, Liliana-Lucia; Rivera-Martínez, Norma E; Dobryanska, Marta; Birlutiu, Victoria; Miftode, Egidia G; Gaibu, Natalia; Caliman-Sturdza, Olga; Florescu, Simin-Aysel; Shi, Hye Jin; Streinu-Cercel, Anca; Streinu-Cercel, Adrian; Lee, Sang Joon; Kim, Sung Hyun; ...
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 8(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis. (17th June 2021)

Authors:
Furst, Daniel E; Jaworski, Janusz; Wojciechowski, Rafal; Wiland, Piotr; Dudek, Anna; Krogulec, Marek; Jeka, Slawomir; Zielinska, Agnieszka; Trefler, Jakub; Bartnicka-Maslowska, Katarzyna; Krajewska-Wlodarczyk, Magdalena; Klimiuk, Piotr A; Lee, Sang Joon; Kim, Sung Hyun; Bae, Yun Ju; Yang, Go Eun;...
Journal:
Rheumatology
Issue:
Volume 61:Number 4(2022)
Page Start:
1385
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial. (10th June 2019)

Authors:
Shim, Seung Cheol; Božić-Majstorović, Ljubinka; Berrocal Kasay, Alfredo; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco Fidencio; Medina-Rodriguez, Francisco G; Miranda, Pedro; Shesternya, Pavel; Chavez-Corrales, Jose; Wiland, Piotr; Jeka, Slawomir; Garmish, Olena; ...
Journal:
Rheumatology
Issue:
Volume 58:Number 12(2019)
Page Start:
2193
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. Issue 8 (August 2017)

Authors:
Kim, Won Seog; Buske, Christian; Ogura, Michinori; Jurczak, Wojciech; Sancho, Juan-Manuel; Zhavrid, Edvard; Kim, Jin Seok; Hernández-Rivas, José-Ángel; Prokharau, Aliaksandr; Vasilica, Mariana; Nagarkar, Rajinish; Osmanov, Dzhelil; Kwak, Larry W; Lee, Sang Joon; Lee, Sung Young; Bae, Yun Ju; Coif...
Journal:
Lancet
Issue:
Volume 4:Issue 8(2017)
Page Start:
e362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial. Issue 11 (November 2018)

Authors:
Ogura, Michinori; Sancho, Juan Manuel; Cho, Seok-Goo; Nakazawa, Hideyuki; Suzumiya, Junji; Tumyan, Gayane; Kim, Jin Seok; Lennard, Anne; Mariz, José; Ilyin, Nikolai; Jurczak, Wojciech; Lopez Martinez, Aurelio; Samoilova, Olga; Zhavrid, Edvard; Yañez Ruiz, Eduardo; Trneny, Marek; Popplewell, Lesli...
Journal:
Lancet
Issue:
Volume 5:Issue 11(2018)
Page Start:
e543
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects. Issue 4 (2nd March 2021)

Authors:
Yu, Kyung‐Sang; Jang, In‐Jin; Lim, Hyeong‐Seok; Hong, Jang Hee; Kim, Min‐Gul; Park, Min Kyu; Cho, Doo‐Yeoun; Park, Min Soo; Chung, Jae Yong; Ghim, Jong‐Lyul; Lee, SeungHwan; Yoon, Seok Kyu; Kwon, In Sun; Lee, Sang Joon; Kim, Sung Hyun; Bae, Yun Ju; Cha, Jung Bin; Furst, Daniel E.; Keystone, Edwar...
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 4(2021)
Page Start:
1280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects. Issue 11 (9th May 2021)

Authors:
Davidson, Antonia; Brimhall, Darin; Kay, Jonathan; Keystone, Edward; Lee, Sang Joon; Kim, Sung Hyun; Bae, Yun Ju; Choi, Eun Jin; Furst, Daniel E.
Journal:
British journal of clinical pharmacology
Issue:
Volume 87:Issue 11(2021)
Page Start:
4323
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗